ArticleThe EPMA journal2016

First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).

Mikhail Paltsev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.